Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

Clinical trial NCT06574789 · RECRUITING

Trial details

NCT number: NCT06574789
Sponsor: Murdoch Childrens Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Viraemia

Start date: 2024-10-29
Primary completion: 2028-06-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.